Upgrade to SI Premium - Free Trial

ContraFect Corp. (CFRX) PT Raised to $17.50 at Chardan Capital Markets

March 16, 2021 10:36 AM
Chardan Capital Markets analyst Keay Nakae raised the price target on ContraFect Corp. (NASDAQ: CFRX) to $17.50 (from $15.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles